STAT+: Are stem cells the next peptides? These advocates think RFK Jr. could make it happen

Summary

Advocates are hoping that stem cell treatments will gain FDA legitimacy similar to peptides following the inclusion of peptides in MAHA initiatives. The article discusses potential regulatory pathways for stem cell treatments under the new administration.